Atezolizumab plus Bevacizumab Versus Sunitinib for Patients with Untreated Metastatic Renal Cell Carcinoma and Sarcomatoid Features: A Prespecified Subgroup Analysis of the IMmotion151 Clinical Trial

DSpace Repository

Atezolizumab plus Bevacizumab Versus Sunitinib for Patients with Untreated Metastatic Renal Cell Carcinoma and Sarcomatoid Features: A Prespecified Subgroup Analysis of the IMmotion151 Clinical Trial

Author: Rini, Brian, I; Motzer, Robert J.; Powles, Thomas; McDermott, David F.; Escudier, Bernard; Donskov, Frede; Hawkins, Robert; Bracarda, Sergio; Bedke, Jens; De Giorgi, Ugo; Porta, Camillo; Ravaud, Alain; Parnis, Francis; Grande, Enrique; Zhang, Wei; Huseni, Mahrukh; Carroll, Susheela; Sufan, Roxana; Schiff, Christina; Atkins, Michael B.
Tübinger Autor(en):
Bedke, Jens
Published in: European Urology (2021), Bd. 79, H. 5, S. 659-662
Verlagsangabe: Elsevier
Language: English
Full text: http://dx.doi.org/10.1016/j.eururo.2020.06.021
ISSN: 1873-7560
DDC Classifikation: 610 - Medicine and health
Dokumentart: Article
Show full item record

This item appears in the following Collection(s)